Back to Search
ARNOLD M HERSKOVIC MD
MD
Radiation Oncology Physician
NPI: 1538185095IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine Physician
Family Medicine
Code: 207Q00000X
036097303(IL)
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
5146-320(WI)036097303(IL)036-097303(IL)
Therapeutic Radiology Physician
Radiology — Therapeutic Radiology
Code: 2085R0203X
EMC0006393(MI)
General Practice Physician
General Practice
Code: 208D00000X
036097303(IL)
Education
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Class of 1969
Research & Publications (10)
Accelerated hyperfractionation in patients with non-small cell bronchogenic cancers as a cost-effective and user- and patient-friendly schedule.
PMID 10923102·Cancer Invest·2000
8-other
Accelerated hyperfractionation for bronchogenic cancer: Radiation Therapy Oncology Group 9205.
PMID 10776986·Am J Clin Oncol·2000
3-trial
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
PMID 15893008·Lung Cancer·2005
3-trial
Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.
PMID 15050316·Int J Radiat Oncol Biol Phys·2004
8-other
Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
PMID 15224032·J Thorac Cardiovasc Surg·2004
3-trial
The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.
PMID 12871784·Lung Cancer·2003
8-other
Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer.
PMID 14512191·Lung Cancer·2003
3-trial
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.
PMID 12234700·Lung Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 300 NORTH AVE
BATTLE CREEK, MI 49017 - Phone
- (269) 245-8056
Quick Facts
- NPI
- 1538185095
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 6
- Locations
- 4
- Years in Practice
- 57
- Publications
- 10
Are you this provider?
Claim Your Profile